Locations

Family Medicine-South Providence
551 E Southampton Dr
Columbia, MO

Phone: (573) 884-7733

Fax: 573-882-6228

Get Directions

1. Family Medicine-South Providence

551 E Southampton Dr
Columbia, MO
Phone: 573-884-7733
Other Phone Numbers:
Phone: (573) 884-7733
Fax: 573-882-6228
View Details
Get Directions

Profile

Michael LeFevre, MD, joined the MU Family and Community Medicine faculty in 1984 after graduating from medical school, completing residency and academic fellowship training and earning his Masters of Science in Public Health (MSPH) degree here at the University of Missouri. He teaches residents and medical students in inpatient and outpatient settings and maintains an active practice across the full breadth of family medicine, including inpatient work and — through 2012 — obstetrics.

Gender

Male

Education & Training

Medical School

University of Missouri School of Medicine

Residency

Family Medicine

  • University of Missouri Health Care

Post-Graduate School

University of Missouri School of Medicine

Boards

American Board of Family Medicine

Insurances

MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.

Academic Information

Professor and Interim Chair
Medical Director of Population Health, MU Health Care
Future of Family Medicine Professor

Office

One Hospital Drive
M226 Medical Sciences Building, DC032.00
Columbia, MO 65212
United States

P. 573-882-1758

Research Profile

Michael LeFevre, MD, served as Chief Medical Information Officer for MU Health Care and directed the implementation of the electronic medical record across the system from 2002 through 2012. Much of his academic effort has been in the area of evidence-based medicine and clinical policies, and he completed more than a decade of work on the United States Preventive Services Task Force in April of 2016, including three years as co-vice chair and a year as chair. Dr. LeFevre was elected to the Institute of Medicine (now National Academy of Medicine) in 2011.

In his free time, Dr. LeFevre enjoys fishing and photography. He and his wife Judith met in Marching Mizzou in college and share a love of family and the arts.

Awards & Honors

2013

MU School of Medicine/Medical Alumni Organization Citation of Merit

University of Missouri Faculty-Alumni Award

2011

National Academy of Medicine Member (formerly Institute of Medicine)

Publications

2019

Report from the FMAHealth Practice Core Team: achieving the quadruple aim through practice transformation.
Family Medicine. 2019;51(2):193-197.
Marker JE, Davis KN, Etz R, Jones SM, Lee JW, LeFevre M, Phillips R.

The role of home BP monitoring: Answers to 10 common questions: How does home BP monitoring stack up against clinic and ambulatory measurements for the Dx and management of hypertension? Find out in this review.
Journal of Family Practice. 2019;68(1):29-33.
Patil SJ, Koopman RJ, Belden J, LeFevre M.

2018

ACC/AHA Hypertension Guideline: What Is New? What Do We Do?
American Family Physician. 2018;97(6):372-373.
LeFevre M.

Vitamin D screening and supplementation in community-dwelling adults: common questions and answers.
American Family Physician. 2018;97(4):254-260.
LeFevre ML, LeFevre NM.

2017

Atrial fibrillation guideline summary.
Annals of Family Medicine. 2017;15(5):490-491.
Frost JL, Campos-Outcalt D, Hoelting D, LeFevre M, Lin KW, Vaughan W, Bird MD.

From authority to evidence-based medicine: are clinical practice guidelines moving us forward or backward?
Annals of Family Medicine. 2017;15(5):410-412.
LeFevre ML.

It matters what is measured.
Journal of the American Board of Family Medicine: JABFM. 2017;30(1):8-9.
LeFevre ML.

Pharmacologic treatment of hypertension in adults 60 years and older: a guideline you can trust.
American Family Physician. 2017;95(9):547-548.
LeFevre ML, James PA.

Update on the methods of the US Preventive Services Task Force: linking intermediate outcomes and health outcomes in prevention.
American Journal of Preventive Medicine. 2018;54(1S1):S4-S10.
Wolff TA, Krist AH, LeFevre M, Jonas DE, Harris RP, Siu A, Owens DK, Gillman MW, Ebell MH, Herzstein J, Chou R, Whitlock E, Bibbins-Domingo K.

2016

Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement.
Annals of Internal Medicine. 2016;164(12):836-845.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr., Garc+¡a FAR, Gillman M, Harper DM, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phillips WR, Phipps MG, Pignone MP, Siu AL, Owens DK, LeFevre ML.

Convergence and divergence around breast cancer screening.
Annals of Internal Medicine. 2016;164(4):301-302.
Siu AL, Bibbins-Domingo K, Grossman DC, LeFevre ML, U.S.Preventive Services Task Force.

In individuals at intermediate risk for cardiovascular disease, treatment with rosuvastatin but not candesartan plus hydrochlorothiazide lowers cardiovascular disease even rates.
Evidence Based Medicine. 2016;DOI: 10.1136/ebmed-2016-110523
LeFevre ML.

Is it time for the USPSTF to inform-but not determine-coverage?
Annals of Internal Medicine. 2016;165(12):876-877.
Moyer VA, LeFevre M, Calonge N.

Screening for lipid disorders in children and adolescents US Preventive Services Task Force recommendation statement.
JAMA. 2016;316(6):625-633.
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr., Garcia FAR, Gillman MW, Kemper AR, Krist AH, Kurth AE, Seth Landefeld C, LeFevre M, Mangione CM, Phillips WR, Phipps MG, Pignone MP, Siu AL.

Sexually transmitted infections: recommendations from the U.S. Preventive Services Task Force.
American Family Physician. 2016;94(11):907-915.
Lee KC, Ngo-Metzger Q, Wolff T, Chowdhury J, LeFevre ML, Meyers DS.

Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement.
JAMA. 2016;316(19):1997-2007.
US Preventive Services, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Jr., Garcia FA, Gillman MW, Kemper AR, Krist AH, Kurth AE, Landefeld CS, LeFevre ML, Mangione CM, Phillips WR, Owens DK, Phipps MG, Pignone MP.

Use of decision models in the development of evidence-based clinical preventive services recommendations: methods of the U.S. Preventive Services Task Force.
Annals of Internal Medicine. 2016;165(7):501-508.
Owens DK, Whitlock EP, Henderson J, Pignone MP, Krist AH, Bibbins-Domingo K, Curry SJ, Davidson KW, Ebell M, Gillman MW, Grossman DC, Kemper AR, Kurth AE, Maciosek M, Siu AL, LeFevre ML, U.S.Preventive Services Task Force.

2015

Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement.
Annals of Internal Medicine. 2015;162(9):641-650.
LeFevre ML, U.S. Preventive Services Task Force.

Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement.
Annals of Internal Medicine. 2015;162(2):133-140.
LeFevre ML, U.S. Preventive Services Task Force.

Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Summaries for Patients.
Annals of Internal Medicine. 2015;162(2):I-28
LeFevre ML, U.S. Preventive Services Task Force.

Update on the methods of the US Preventive Services Task Force: methods for understanding certainty and net benefit when making recommendations.
American Journal of Preventive Medicine. 2018;54(1S1):S11-S18.
Krist AH, Wolff TA, Jonas DE, Harris RP, LeFevre ML, Kemper AR, Mangione CM, Tseng CW, Grossman DC.